Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.

Ng CH, Janoo-Gilani R, Sipahimalani P, Gallagher RP, Gascoyne RD, Connors JM, Weber JP, Lai AS, Leach S, Le ND, Brooks-Wilson AR, Spinelli JJ.

Cancer Causes Control. 2010 Jan;21(1):11-22. doi: 10.1007/s10552-009-9429-5. Epub 2009 Sep 26.

PMID:
19821039
2.

Organochlorines and risk of non-Hodgkin lymphoma.

Spinelli JJ, Ng CH, Weber JP, Connors JM, Gascoyne RD, Lai AS, Brooks-Wilson AR, Le ND, Berry BR, Gallagher RP.

Int J Cancer. 2007 Dec 15;121(12):2767-75.

3.

Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma.

Hardell K, Carlberg M, Hardell L, Björnfoth H, Ericson Jogsten I, Eriksson M, Van Bavel B, Lindström G.

Oncol Rep. 2009 Jun;21(6):1567-76.

PMID:
19424638
4.

Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population.

Chen D, Tian T, Wang H, Liu H, Hu Z, Wang Y, Liu Y, Ma H, Fan W, Miao R, Sun W, Wang Y, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D.

Pharmacogenet Genomics. 2009 Jan;19(1):25-34. doi: 10.1097/FPC.0b013e328316d8d8.

PMID:
18818557
5.

Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes.

Cocco P, Brennan P, Ibba A, de Sanjosé Llongueras S, Maynadié M, Nieters A, Becker N, Ennas MG, Tocco MG, Boffetta P.

Occup Environ Med. 2008 Feb;65(2):132-40. Epub 2007 Aug 15.

PMID:
17699548
6.

Organochlorines in carpet dust and non-Hodgkin lymphoma.

Colt JS, Severson RK, Lubin J, Rothman N, Camann D, Davis S, Cerhan JR, Cozen W, Hartge P.

Epidemiology. 2005 Jul;16(4):516-25.

PMID:
15951670
7.

Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.

Novik KL, Spinelli JJ, Macarthur AC, Shumansky K, Sipahimalani P, Leach S, Lai A, Connors JM, Gascoyne RD, Gallagher RP, Brooks-Wilson AR.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1098-106.

8.

Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma.

Hardell E, Eriksson M, Lindström G, Van Bavel B, Linde A, Carlberg M, Liljegren G.

Leuk Lymphoma. 2001 Aug;42(4):619-29.

PMID:
11697490
9.

Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients.

Baris D, Kwak LW, Rothman N, Wilson W, Manns A, Tarone RE, Hartge P.

Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):193-7.

10.

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, Chatterjee N, Yeager M, Chanock SJ, Rothman N.

Cancer Res. 2006 Oct 1;66(19):9771-80.

11.

Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.

Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ.

Br J Haematol. 2008 Feb;140(3):287-94. Epub 2007 Nov 27.

PMID:
18042267
12.

Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.

Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK.

Haematologica. 2007 Sep;92(9):1180-5. Epub 2007 Aug 1.

13.

Modifying effect of the AR gene trinucleotide repeats and SNPs in the AHR and AHRR genes on the association between persistent organohalogen pollutant exposure and human sperm Y:X ratio.

Tiido T, Rignell-Hydbom A, Jönsson BA, Rylander L, Giwercman A, Giwercman YL.

Mol Hum Reprod. 2007 Apr;13(4):223-9. Epub 2007 Jan 23.

PMID:
17244640
14.

Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

Hu W, Bassig BA, Xu J, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD 3rd, Leaderer B, Yeager M, Menashe I, Boyle P, Zou K, Zhu Y, Chanock S, Lan Q, Rothman N.

Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.

PMID:
23055202
15.

Family history of hematopoietic malignancy and risk of lymphoma.

Chang ET, Smedby KE, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, Adami HO.

J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74.

PMID:
16204696
16.

The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations.

Wang XW, Li K, Guo S, Qiang HN, Liu L, Song P, Wei C, Yi XL, Jian Z, Li Q, Li CY, Gao TW.

Br J Dermatol. 2012 May;166(5):1081-7. doi: 10.1111/j.1365-2133.2011.10798.x.

PMID:
22211302
17.

Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.

Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G, Reverberi R, Caruso A, Pasello M, Pellati A, De Mattei M.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):787-94.

18.

Association between non-Hodgkin lymphoma and haplotypes in the TNF region.

Spink CF, Keen LJ, Mensah FK, Law GR, Bidwell JL, Morgan GJ.

Br J Haematol. 2006 May;133(3):293-300.

PMID:
16643431
19.

Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W.

Pharmacogenet Genomics. 2006 Apr;16(4):237-43.

PMID:
16538170
20.

Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.

Kim HN, Yu L, Kim NY, Lee IK, Kim YK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Kim HJ.

Am J Hematol. 2010 Oct;85(10):822-4. doi: 10.1002/ajh.21834.

Supplemental Content

Support Center